|
|
||||||||
The Journal of Immunology, Vol 157, Issue 4 1523-1528, Copyright © 1996 by American Association of Immunologists
ARTICLES |
H Yamada, K Kishihara, YY Kong and K Nomoto
Department of Immunology, Kyushu University, Fukuoka, Japan.
CD45 is a cell membrane-type protein tyrosine phosphatase that is essential for Ag receptor-mediated signaling in both T and B lymphocytes. To characterize roles of CD45 molecules in murine NK cells, we analyzed the development and the cytotoxic functions of NK cells in mice lacking CD45 exon 6 (CD45 -/-). A markedly increased number of NK cells was observed in spleens of the CD45 -/- mice, despite no CD45 surface expression on the NK cells. From the results of mixed bone marrow chimera experiments, it was demonstrated that the expansion of NK cells in CD45 -/- mice was due to the influence of disappeared expression of CD45 in the NK cells per se, but not to the modulation of environmental factors. The NK cells in the CD45 -/- mice had normal cytotoxic activities, including NK and Ab-dependent cell- mediated cytotoxicity activities comparable with those in normal mice (CD45 +/+). Additionally, the CD45 -/- NK cells could functionally differentiate to lymphokine-activated killer cells by culturing with a high dose of IL-2, despite a lack of induced expression of B220. Therefore, these results suggest that CD45 is involved in NK cell development, but is not essential for cytotoxic activities and Fc gamma R-mediated signaling in NK cells.
This article has been cited by other articles:
![]() |
L. H. Mason, J. Willette-Brown, L. S. Taylor, and D. W. McVicar Regulation of Ly49D/DAP12 Signal Transduction by Src-Family Kinases and CD45. J. Immunol., June 1, 2006; 176(11): 6615 - 6623. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. T. Hesslein, R. Takaki, M. L. Hermiston, A. Weiss, and L. L. Lanier Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production PNAS, May 2, 2006; 103(18): 7012 - 7017. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Huntington, Y. Xu, S. L. Nutt, and D. M. Tarlinton A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells J. Exp. Med., May 2, 2005; 201(9): 1421 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Esplugues, D. Sancho, J. Vega-Ramos, C. Martinez-A, U. Syrbe, A. Hamann, P. Engel, F. Sanchez-Madrid, and P. Lauzurica Enhanced Antitumor Immunity in Mice Deficient in CD69 J. Exp. Med., May 5, 2003; 197(9): 1093 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jevremovic, D. D. Billadeau, R. A. Schoon, C. J. Dick, and P. J. Leibson Regulation of NK Cell-Mediated Cytotoxicity by the Adaptor Protein 3BP2 J. Immunol., June 15, 2001; 166(12): 7219 - 7228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Martin, I. K. Mehta, W. M. Yokoyama, M. L. Thomas, and R. G. Lorenz Development of Intestinal Intraepithelial Lymphocytes, NK Cells, and NK 1.1+ T Cells in CD45-Deficient Mice J. Immunol., May 15, 2001; 166(10): 6066 - 6073. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lindberg, A. Martin-Fontecha, and P. Hoglund Natural killing of MHC class I– lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors Int. Immunol., August 1, 1999; 11(8): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Giezeman-Smits, A. Gorter, R. L. P. van Vlierberghe, J. D. H. v. Eendenburg, A. M. M. Eggermont, G. J. Fleuren, and P. J. K. Kuppen The Regulatory Role of CD45 on Rat NK Cells in Target Cell Lysis J. Immunol., July 1, 1999; 163(1): 71 - 76. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |